Item 1A. Risk Factors   Information regarding risk factors is discussed in Item 1A, “Risk Factors” of the Company’s Form 10-K for the year ended December 31, 2008. There have been no material changes from the risk factors previously disclosed in the Company’s Form 10-K.   Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   The following table sets forth the Company’s repurchases of equity securities registered under Section 12 of the Exchange Act that occurred in the three months ended March 31, 2009.      Period       Total number of shares (or units) purchased (a)       Average price paid per share (or unit)       Total number of shares (or units) purchased as part of publicly announced plans or programs       Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (b)                                           January 2009 (January 1 – January 31)       3,330       $ 32.97       –       8,385,400                                           February 2009 (February 1 – February 28)       3,256       $ 34.93       –       8,385,400                                           March 2009 (March 1 – March 31)       3,646       $ 30.96       –       8,385,400                                           Total       10,232               –              (a) Comprised solely of Company-directed purchases made by the Company’s 401(k) plans.   (b) EQT’s Board of Directors previously authorized a share repurchase program with a maximum of 50.0 million shares and no expiration date. The program was initially publicly announced on October 7, 1998 with subsequent amendments announced on November 12, 1999, July 20, 2000, April 15, 2004 and July 13, 2005.   Item 5. Other Information   On February 17, 2009, Ernst & Young LLP consented (the “Consent”) to the incorporation by reference in certain of the Company’s Registration Statements of its reports dated February 17, 2009, with respect to the consolidated financial statements and schedule of the Company, and the effectiveness of internal control over financial reporting of the Company, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008. The Consent was attached as Exhibit 23.01 to the Company’s Annual Report on Form 10-K. However, due to an administrative error, the Exhibit omitted the signature of Ernst & Young LLP. A fully executed copy of the Consent is attached as Exhibit 23.1 hereto and is incorporated herein by reference.     38     Table of Contents   PART II. OTHER INFORMATION     Item 6. Exhibits